Eli Lilly to launch three drugs in 2003
Financial Times (subscription), UK - 9 hours ago
... Lilly on Friday provided a clearer timetable for the US launch of Strattera, an attention
deficit and hyperactivity disorder drug, Forteo for osteoporosis, and ...

Eli Lilly Submits 2 Drugs for Review
Newsday - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Eli Lilly Submits 2 Drugs for Review
Newsday - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Lilly Submits Two New Drugs For Federal Review
WRTV, IN - 08 Nov 2002
... It also said manufacturing issues will not affect approval of Strattera, which treats
attention-deficit disorder and hyperactivity, and Cialis, an impotence ...

Eli Lilly Maps Out New Drugs, Other Plans
ABC News - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Maps Out New Drugs, Other Plans
Reuters, UK - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Submits 2 Drugs for Review
Austin American Statesman, TX - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Eli Lilly Submits 2 Drugs for Review
ABC News - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Eli Lilly Submits 2 Drugs for Review
Seattle Post Intelligencer, WA - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Eli Lilly Submits 2 Drugs for Review
Sarasota Herald-Tribune, FL - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Eli Lilly Submits 2 Drugs for Review
Miami Herald, FL - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Eli Lilly Submits 2 Drugs for Review
Times Daily, AL - 08 Nov 2002
... It also said manufacturing issues will not affect the approval of Strattera,
which treats attention-deficit disorder and hyperactivity, and Cialis, an ...

Eli Lilly Maps Out New Drugs, Other Plans
ABC News - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Lilly says 3 drugs to debut in 2003
Indianapolis Star, IN - 08 Nov 2002
... an interview. The attention-deficit treatment Strattera and the impotence
drug Cialis aren't affected either, he said. "That's the ...

Eli Lilly Maps Out New Drugs, Other Plans
Reuters, UK - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Maps Out New Plans
ABC News - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Maps Out New Plans
Reuters, UK - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Says Manufacturing Issues Won't Affect Three Approvals
The Gay Financial Network - 08 Nov 2002
... there aren't any outstanding manufacturing issues that would prevent US approval
for the osteoporosis drug, Forteo, or the attention disorder drug, Strattera. ...

Eli Lilly maps out new drugs, manufacturing plans
USA Today - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Says Manufacturing Issues Won't Affect Three Approvals
TheStreet.com, NY - 08 Nov 2002
... there aren't any outstanding manufacturing issues that would prevent US approval
for the osteoporosis drug, Forteo, or the attention disorder drug, Strattera. ...

Lilly sets plan for new drugs
CNN - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Maps New Drugs, Manufacturing
Reuters, UK - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Maps New Drugs, Manufacturing
ABC News - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly Maps New Drugs, Manufacturing
Reuters, UK - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Eli Lilly maps out new drugs, manufacturing plans
Forbes - 08 Nov 2002
... not have any outstanding manufacturing issues that would prevent US approval for
new osteoporosis drug Forteo or for new attention deficit medicine Strattera. ...

Potential new ADHD drug creating lots of big hopes
Sacramento Bee, CA - 30 Oct 2002
... Eli Lilly, the creator of atomoxetine -- which will be sold as Strattera -- say
the drug stands out because it is not a stimulant, as are other drugs for ADHD ...

Potential new ADHD drug creating lots of big hopes
Sacramento Bee, CA - 30 Oct 2002
... Eli Lilly, the creator of atomoxetine -- which will be sold as Strattera -- say
the drug stands out because it is not a stimulant, as are other drugs for ADHD ...

Lilly shares decline
WTHR, IN - 25 Oct 2002
... FDA approval of two other drugs produced outside Indianapolis: Cialis, a medication
for male erectile dysfunction that could compete with Viagra, and Strattera ...

Lilly shares decline
WTHR, IN - 24 Oct 2002
... FDA approval of two other drugs produced outside Indianapolis: Cialis, a medication
for male erectile dysfunction that could compete with Viagra, and Strattera ...

Lilly Shares Take Beating Despite Earnings Increase
WRTV, IN - 23 Oct 2002
... FDA approval of two other drugs produced outside Indianapolis: Cialis, a medication
for male erectile dysfunction that could compete with Viagra, and Strattera ...

Eli Lilly Profits Rise 20 Percent
WFTV, FL - 23 Oct 2002
... Lilly is awaiting FDA approval of two other drugs: Cialis, a medication for male
erectile dysfunction that could compete with Viagra, and Strattera, for ...

Eli Lilly Profits Rise 20 Percent
Austin American Statesman, TX - 23 Oct 2002
... Lilly is awaiting FDA approval of two other drugs: Cialis, a medication for male
erectile dysfunction that could compete with Viagra, and Strattera, for ...

Lilly shares decline despite 20 percent earnings increase
Henderson Gleaner, KY - 23 Oct 2002
... FDA approval of two other drugs produced outside Indianapolis: Cialis, a medication
for male erectile dysfunction that could compete with Viagra, and Strattera ...

Eli Lilly Profits Rise 20 Percent
ABC News - 23 Oct 2002
... Lilly is awaiting FDA approval of two other drugs: Cialis, a medication for male
erectile dysfunction that could compete with Viagra, and Strattera, for ...

Lilly shares decline
WTHR, IN - 23 Oct 2002
... FDA approval of two other drugs produced outside Indianapolis: Cialis, a medication
for male erectile dysfunction that could compete with Viagra, and Strattera ...